Posts

Federal AI experiment could transform chronic care if doctors and patients want it

The story is about a federal Medicare experiment called ACCESS that could reshape chronic care by paying for outcomes instead of office visits. ACCESS is designed to support technology-enabled care for chronic conditions such as diabetes, hypertension, obesity, chronic kidney disease, depression, anxiety, and chronic pain. The model would let health systems, startups, and device makers use AI tools, wearables, apps, and remote monitoring to manage patients between visits. Related federal efforts include an ARPA-H program called ADVOCATE, which is building an autonomous AI system for cardiovascular care, and an FDA pilot called TEMPO, which lets some AI-enabled health tools reach patients before full approval while real-world data is collected. The big question in the article is whether doctors and patients will trust and adopt these AI-supported care models enough for them to succeed. Sources: The government wants AI doctors OpenAI's Latest Experiment Should Change Ho...

Iambic files for IPO after building momentum with Big Pharma partnerships

Novartis licenses preclinical radioligand asset from BoomRay in deal worth up to $900M

Bristol Myers Squibb cuts another 265 jobs tied to New Jersey headquarters

Vertex pursues broader inaxaplin opportunity ahead of 2027 pivotal kidney-disease data

DPHARM: Community-based trials, patient-centered design and EHR AI proposed to ease enrollment crisis

Angle Health becomes a $2.7B health-benefits unicorn in $600M financing

Experimental epigenetic CRISPR therapy silences hepatitis B DNA without cutting it

Cue Biopharma’s CUE-221 shows promising Phase 2 results against chronic hives

ADARx raises IPO target as TRex Bio and Retension join biotech filing wave

Iambic launches Enchant v3 and signs multi-year AbbVie drug-discovery deal

Ivonescimab Biliary Tract Cancer Survival Data Selected for ESMO 2026 Presidential Symposium

Ultragenyx wins FDA approval for first treatment for Sanfilippo syndrome type A